Global and United States Subcutaneous Immunotherapy Market Report & Forecast 2023-2028

Report ID: 1825800 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Subcutaneous Immunotherapy Revenue in Subcutaneous Immunotherapy Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Subcutaneous Immunotherapy Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Subcutaneous Immunotherapy Market Size for the Year 2017-2028
        1.2.2 Global Subcutaneous Immunotherapy Market Size for the Year 2017-2028
    1.3 Subcutaneous Immunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Subcutaneous Immunotherapy in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Subcutaneous Immunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Subcutaneous Immunotherapy Market Dynamics
        1.4.1 Subcutaneous Immunotherapy Industry Trends
        1.4.2 Subcutaneous Immunotherapy Market Drivers
        1.4.3 Subcutaneous Immunotherapy Market Challenges
        1.4.4 Subcutaneous Immunotherapy Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Subcutaneous Immunotherapy by Type
    2.1 Subcutaneous Immunotherapy Market Segment by Type
        2.1.1 Asthma
        2.1.2 Allergic Rhinitis
        2.1.3 Venom Allergy
        2.1.4 Food Allergy
    2.2 Global Subcutaneous Immunotherapy Market Size by Type (2017, 2022 & 2028)
    2.3 Global Subcutaneous Immunotherapy Market Size by Type (2017-2028)
    2.4 United States Subcutaneous Immunotherapy Market Size by Type (2017, 2022 & 2028)
    2.5 United States Subcutaneous Immunotherapy Market Size by Type (2017-2028)
3 Subcutaneous Immunotherapy by Application
    3.1 Subcutaneous Immunotherapy Market Segment by Application
        3.1.1 Hospital Pharmacies
        3.1.2 Online Pharmacies
        3.1.3 Retail Pharmacies
    3.2 Global Subcutaneous Immunotherapy Market Size by Application (2017, 2022 & 2028)
    3.3 Global Subcutaneous Immunotherapy Market Size by Application (2017-2028)
    3.4 United States Subcutaneous Immunotherapy Market Size by Application (2017, 2022 & 2028)
    3.5 United States Subcutaneous Immunotherapy Market Size by Application (2017-2028)
4 Global Subcutaneous Immunotherapy Competitor Landscape by Company
    4.1 Global Subcutaneous Immunotherapy Market Size by Company
        4.1.1 Top Global Subcutaneous Immunotherapy Companies Ranked by Revenue (2021)
        4.1.2 Global Subcutaneous Immunotherapy Revenue by Player (2017-2022)
    4.2 Global Subcutaneous Immunotherapy Concentration Ratio (CR)
        4.2.1 Subcutaneous Immunotherapy Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Subcutaneous Immunotherapy in 2021
        4.2.3 Global Subcutaneous Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Subcutaneous Immunotherapy Headquarters, Revenue in Subcutaneous Immunotherapy Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Subcutaneous Immunotherapy Headquarters and Area Served
        4.3.2 Global Subcutaneous Immunotherapy Companies Revenue in Subcutaneous Immunotherapy Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Subcutaneous Immunotherapy Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Subcutaneous Immunotherapy Market Size by Company
        4.5.1 Top Subcutaneous Immunotherapy Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Subcutaneous Immunotherapy Revenue by Players (2020, 2021 & 2022)
5 Global Subcutaneous Immunotherapy Market Size by Region
    5.1 Global Subcutaneous Immunotherapy Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Subcutaneous Immunotherapy Market Size by Region (2017-2028)
        5.2.1 Global Subcutaneous Immunotherapy Market Size by Region: 2017-2022
        5.2.2 Global Subcutaneous Immunotherapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Subcutaneous Immunotherapy Market Size YoY Growth 2017-2028
        6.1.2 North America Subcutaneous Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Subcutaneous Immunotherapy Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Subcutaneous Immunotherapy Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Subcutaneous Immunotherapy Market Size YoY Growth 2017-2028
        6.3.2 Europe Subcutaneous Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Subcutaneous Immunotherapy Market Size YoY Growth 2017-2028
        6.4.2 Latin America Subcutaneous Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Subcutaneous Immunotherapy Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Subcutaneous Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Anergis
        7.1.1 Anergis Company Details
        7.1.2 Anergis Business Overview
        7.1.3 Anergis Subcutaneous Immunotherapy Introduction
        7.1.4 Anergis Revenue in Subcutaneous Immunotherapy Business (2017-2022)
        7.1.5 Anergis Recent Development
    7.2 HAL Allergy Group
        7.2.1 HAL Allergy Group Company Details
        7.2.2 HAL Allergy Group Business Overview
        7.2.3 HAL Allergy Group Subcutaneous Immunotherapy Introduction
        7.2.4 HAL Allergy Group Revenue in Subcutaneous Immunotherapy Business (2017-2022)
        7.2.5 HAL Allergy Group Recent Development
    7.3 Merck
        7.3.1 Merck Company Details
        7.3.2 Merck Business Overview
        7.3.3 Merck Subcutaneous Immunotherapy Introduction
        7.3.4 Merck Revenue in Subcutaneous Immunotherapy Business (2017-2022)
        7.3.5 Merck Recent Development
    7.4 Allergy Therapeutics
        7.4.1 Allergy Therapeutics Company Details
        7.4.2 Allergy Therapeutics Business Overview
        7.4.3 Allergy Therapeutics Subcutaneous Immunotherapy Introduction
        7.4.4 Allergy Therapeutics Revenue in Subcutaneous Immunotherapy Business (2017-2022)
        7.4.5 Allergy Therapeutics Recent Development
    7.5 ALK-Abello
        7.5.1 ALK-Abello Company Details
        7.5.2 ALK-Abello Business Overview
        7.5.3 ALK-Abello Subcutaneous Immunotherapy Introduction
        7.5.4 ALK-Abello Revenue in Subcutaneous Immunotherapy Business (2017-2022)
        7.5.5 ALK-Abello Recent Development
    7.6 Stallergenes Greer
        7.6.1 Stallergenes Greer Company Details
        7.6.2 Stallergenes Greer Business Overview
        7.6.3 Stallergenes Greer Subcutaneous Immunotherapy Introduction
        7.6.4 Stallergenes Greer Revenue in Subcutaneous Immunotherapy Business (2017-2022)
        7.6.5 Stallergenes Greer Recent Development
    7.7 Laboratorios LETI
        7.7.1 Laboratorios LETI Company Details
        7.7.2 Laboratorios LETI Business Overview
        7.7.3 Laboratorios LETI Subcutaneous Immunotherapy Introduction
        7.7.4 Laboratorios LETI Revenue in Subcutaneous Immunotherapy Business (2017-2022)
        7.7.5 Laboratorios LETI Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Subcutaneous Immunotherapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Subcutaneous Immunotherapy Market Trends
    Table 3. Subcutaneous Immunotherapy Market Drivers
    Table 4. Subcutaneous Immunotherapy Market Challenges
    Table 5. Subcutaneous Immunotherapy Market Restraints
    Table 6. Global Subcutaneous Immunotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Subcutaneous Immunotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Subcutaneous Immunotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Subcutaneous Immunotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Subcutaneous Immunotherapy Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Subcutaneous Immunotherapy Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Subcutaneous Immunotherapy Revenue Share by Player, 2017-2022
    Table 13. Global Subcutaneous Immunotherapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Subcutaneous Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Immunotherapy as of 2021)
    Table 15. Top Players of Subcutaneous Immunotherapy in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Subcutaneous Immunotherapy Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Subcutaneous Immunotherapy Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Subcutaneous Immunotherapy Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Subcutaneous Immunotherapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Subcutaneous Immunotherapy Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Subcutaneous Immunotherapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Subcutaneous Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Subcutaneous Immunotherapy Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Subcutaneous Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Subcutaneous Immunotherapy Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Subcutaneous Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Subcutaneous Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Subcutaneous Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Anergis Company Details
    Table 31. Anergis Business Overview
    Table 32. Anergis Subcutaneous Immunotherapy Product
    Table 33. Anergis Revenue in Subcutaneous Immunotherapy Business (2017-2022) & (US$ Million)
    Table 34. Anergis Recent Development
    Table 35. HAL Allergy Group Company Details
    Table 36. HAL Allergy Group Business Overview
    Table 37. HAL Allergy Group Subcutaneous Immunotherapy Product
    Table 38. HAL Allergy Group Revenue in Subcutaneous Immunotherapy Business (2017-2022) & (US$ Million)
    Table 39. HAL Allergy Group Recent Development
    Table 40. Merck Company Details
    Table 41. Merck Business Overview
    Table 42. Merck Subcutaneous Immunotherapy Product
    Table 43. Merck Revenue in Subcutaneous Immunotherapy Business (2017-2022) & (US$ Million)
    Table 44. Merck Recent Development
    Table 45. Allergy Therapeutics Company Details
    Table 46. Allergy Therapeutics Business Overview
    Table 47. Allergy Therapeutics Subcutaneous Immunotherapy Product
    Table 48. Allergy Therapeutics Revenue in Subcutaneous Immunotherapy Business (2017-2022) & (US$ Million)
    Table 49. Allergy Therapeutics Recent Development
    Table 50. ALK-Abello Company Details
    Table 51. ALK-Abello Business Overview
    Table 52. ALK-Abello Subcutaneous Immunotherapy Product
    Table 53. ALK-Abello Revenue in Subcutaneous Immunotherapy Business (2017-2022) & (US$ Million)
    Table 54. ALK-Abello Recent Development
    Table 55. Stallergenes Greer Company Details
    Table 56. Stallergenes Greer Business Overview
    Table 57. Stallergenes Greer Subcutaneous Immunotherapy Product
    Table 58. Stallergenes Greer Revenue in Subcutaneous Immunotherapy Business (2017-2022) & (US$ Million)
    Table 59. Stallergenes Greer Recent Development
    Table 60. Laboratorios LETI Company Details
    Table 61. Laboratorios LETI Business Overview
    Table 62. Laboratorios LETI Subcutaneous Immunotherapy Product
    Table 63. Laboratorios LETI Revenue in Subcutaneous Immunotherapy Business (2017-2022) & (US$ Million)
    Table 64. Laboratorios LETI Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Subcutaneous Immunotherapy Product Picture
    Figure 2. Global Subcutaneous Immunotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Subcutaneous Immunotherapy Market Size 2017-2028 (US$ Million)
    Figure 4. United States Subcutaneous Immunotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Subcutaneous Immunotherapy Market Size 2017-2028 (US$ Million)
    Figure 6. United States Subcutaneous Immunotherapy Market Share in Global 2017-2028
    Figure 7. Subcutaneous Immunotherapy Report Years Considered
    Figure 8. Product Picture of Asthma
    Figure 9. Product Picture of Allergic Rhinitis
    Figure 10. Product Picture of Venom Allergy
    Figure 11. Product Picture of Food Allergy
    Figure 12. Global Subcutaneous Immunotherapy Market Share by Type in 2022 & 2028
    Figure 13. Global Subcutaneous Immunotherapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Subcutaneous Immunotherapy Market Share by Type (2017-2028)
    Figure 15. United States Subcutaneous Immunotherapy Market Share by Type in 2022 & 2028
    Figure 16. United States Subcutaneous Immunotherapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Subcutaneous Immunotherapy Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospital Pharmacies
    Figure 19. Product Picture of Online Pharmacies
    Figure 20. Product Picture of Retail Pharmacies
    Figure 21. Global Subcutaneous Immunotherapy Market Share by Application in 2022 & 2028
    Figure 22. Global Subcutaneous Immunotherapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Subcutaneous Immunotherapy Market Share by Application (2017-2028)
    Figure 24. United States Subcutaneous Immunotherapy Market Share by Application in 2022 & 2028
    Figure 25. United States Subcutaneous Immunotherapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Subcutaneous Immunotherapy Market Share by Application (2017-2028)
    Figure 27. North America Subcutaneous Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Subcutaneous Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Subcutaneous Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Subcutaneous Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Subcutaneous Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Subcutaneous Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Anergis Revenue Growth Rate in Subcutaneous Immunotherapy Business (2017-2022)
    Figure 56. HAL Allergy Group Revenue Growth Rate in Subcutaneous Immunotherapy Business (2017-2022)
    Figure 57. Merck Revenue Growth Rate in Subcutaneous Immunotherapy Business (2017-2022)
    Figure 58. Allergy Therapeutics Revenue Growth Rate in Subcutaneous Immunotherapy Business (2017-2022)
    Figure 59. ALK-Abello Revenue Growth Rate in Subcutaneous Immunotherapy Business (2017-2022)
    Figure 60. Stallergenes Greer Revenue Growth Rate in Subcutaneous Immunotherapy Business (2017-2022)
    Figure 61. Laboratorios LETI Revenue Growth Rate in Subcutaneous Immunotherapy Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Anergis
HAL Allergy Group
Merck
Allergy Therapeutics
ALK-Abello
Stallergenes Greer
Laboratorios LETI
Frequently Asked Questions
Subcutaneous Immunotherapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Subcutaneous Immunotherapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Subcutaneous Immunotherapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports